Thus, our working hypothesis was that IL-28 functions an intermediate protein in the signaling between MDSCs and tumor cells, which activates STAT3 in neoplastic cells and leads to cancer metastasis and angiogenesis. The gene discussed is STAT3; the disease is cancer.